DMKJ
David M. Knott Jr Portfolio holdings
AUM
$221M
1-Year Return
22.52%
This Quarter Return
+5.62%
1 Year Return
+22.52%
3 Year Return
+148.91%
5 Year Return
–
10 Year Return
–
AUM
$262M
AUM Growth
+$10.7M
(+4.2%)
Cap. Flow
+$1.32M
Cap. Flow
% of AUM
0.5%
Top 10 Holdings %
Top 10 Hldgs %
69.6%
Holding
162
New
14
Increased
11
Reduced
9
Closed
31
Top Buys
| 1 |
Panagram BBB-B CLO ETF
CLOZ
|
$3.16M |
| 2 |
GCVRZ
Sanofi Contingent Value Rights
GCVRZ
|
$3M |
| 3 |
DocGo
DCGO
|
$2.8M |
| 4 |
MOR
MorphoSys AG American Depositary Shares
MOR
|
$2.32M |
| 5 |
United Therapeutics
UTHR
|
$2.02M |
Top Sells
Sector Composition
| 1 | Materials | 34.61% |
| 2 | Healthcare | 25.56% |
| 3 | Financials | 13.62% |
| 4 | Industrials | 6.63% |
| 5 | Communication Services | 5.67% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Dow Inc
DOW
$16.6B
| $574K | 0.22% |
11,136
| – | – |
|
52
Canadian Natural Resources
CNQ
$64.9B
| $543K | 0.21% |
16,800
| – | – |
|
53
Microsoft
MSFT
$3.76T
| $505K | 0.19% |
1,600
| – | – |
|
54
Apple
AAPL
$3.53T
| $427K | 0.16% |
2,494
| – | – |
|
55
Coca-Cola
KO
$297B
| $425K | 0.16% |
7,600
-2,000
| -21% | -$112K |
|
|
SYRS
56
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $419K | 0.16% |
105,975
+9,715
| +10% | +$38.4K |
|
57
Panagram AAA CLO ETF
CLOX
$220M
| $396K | 0.15% |
+15,640
| New | +$396K |
|
58
Johnson & Johnson
JNJ
$429B
| $335K | 0.13% |
2,151
-649
| -23% | -$101K |
|
59
Akero Therapeutics
AKRO
$3.51B
| $325K | 0.12% |
6,419
+4,419
| +221% | +$224K |
|
60
PSQ Holdings
PSQH
$75.8M
| $307K | 0.12% |
+26,666
| New | +$307K |
|
61
IBM
IBM
$228B
| $301K | 0.11% |
2,142
| – | – |
|
62
Xoma
XOMA
$423M
| $278K | 0.11% |
19,722
+4,722
| +31% | +$66.6K |
|
63
Conagra Brands
CAG
$9.13B
| $274K | 0.1% |
10,000
| – | – |
|
64
BridgeBio Pharma
BBIO
$9.78B
| $237K | 0.09% |
+9,000
| New | +$237K |
|
|
BRSL
65
Brightstar Lottery PLC
BRSL
$3.12B
| $227K | 0.09% |
7,500
| – | – |
|
66
89bio
ETNB
$1.31B
| $225K | 0.09% |
+14,574
| New | +$225K |
|
67
FS KKR Capital
FSK
$5.03B
| $225K | 0.09% |
11,425
| – | – |
|
68
Seres Therapeutics
MCRB
$161M
| $167K | 0.06% |
3,500
-20,000
| -85% | -$954K |
|
69
Eli Lilly
LLY
$663B
| $161K | 0.06% |
300
| – | – |
|
70
FS Bancorp
FSBW
$322M
| $129K | 0.05% |
4,380
| – | – |
|
71
Legacy Housing
LEGH
$675M
| $126K | 0.05% |
6,500
| – | – |
|
72
Kenvue
KVUE
$39.2B
| $105K | 0.04% |
+5,215
| New | +$105K |
|
73
TotalEnergies
TTE
$134B
| $105K | 0.04% |
1,600
| – | – |
|
74
FNB Corp
FNB
$5.98B
| $96K | 0.04% |
8,905
| – | – |
|
75
SouthState Bank Corporation
SSB
$10.3B
| $72K | 0.03% |
1,068
| – | – |
|